EDX Medical Group Plc
Develops digital diagnostic products for oncology, cardiology, and infectious diseases.
EDX | Aquis Stock Exchange
Overview
Corporate Details
- ISIN(s):
- GB00BNDMJS47
- LEI:
- 213800BZVJZTMCZ6DJ63
- Country:
- United Kingdom
- Address:
- 211 Cambridge Science Park, CB4 0WA Cambridge
- Website:
- https://edxmedical.com/
- Industry:
- Other human health activities
Description
EDX Medical Group Plc develops and provides digital diagnostic products and services for healthcare professionals. Its solutions are designed for the rapid detection and characterization of major diseases, enabling personalized treatment and improved patient outcomes. The company's primary focus areas are oncology, cardiology, and infectious diseases. Key offerings in oncology include comprehensive tumour profiling using whole exome and transcriptome sequencing, liquid biopsy analysis, and functional ex vivo assays that predict tumour response to specific therapies. The company also develops highly sensitive tests for early detection of cancers such as prostate and testicular cancer. In infectious diseases, EDX Medical develops point-of-care multiplex tests for conditions like sepsis and pneumonia. The company's approach integrates advanced molecular biology, genomic sequencing, and digital technologies across its laboratory-based services and point-of-care devices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-09 08:20 |
Director dealing
|
English | HTML • 33.3 KB | ||
| 2026-01-08 08:25 |
Director dealing
|
English | HTML • 33.8 KB | ||
| 2026-01-06 08:20 |
Director dealing
|
English | HTML • 34.9 KB | ||
| 2026-01-05 08:20 |
Director dealing
|
English | HTML • 34.9 KB | ||
| 2026-01-02 08:25 |
Director dealing
|
English | HTML • 35.5 KB | ||
| 2025-12-23 08:20 |
Director dealing
|
English | HTML • 45.1 KB | ||
| 2025-12-19 13:10 |
Interim report: Six months to 30 September 2025
|
English | HTML • 325.8 KB | ||
| 2025-12-18 08:20 |
Commercial launch of bowel cancer testing service
|
English | HTML • 26.8 KB | ||
| 2025-10-31 08:00 |
Total Voting Rights
|
English | HTML • 15.4 KB | ||
| 2025-10-20 08:00 |
EDX Medical secures up to £4million funding
|
English | HTML • 20.7 KB | ||
| 2025-10-07 12:33 |
Advance testicular cancer testing service launched
|
English | HTML • 20.1 KB | ||
| 2025-09-29 16:58 |
Result of Annual General Meeting
|
English | HTML • 29.5 KB | ||
| 2025-09-04 08:00 |
Director dealing
|
English | HTML • 42.8 KB | ||
| 2025-09-03 12:15 |
Director dealing
|
English | HTML • 45.2 KB | ||
| 2025-09-03 08:00 |
Director dealing
|
English | HTML • 42.9 KB |
Automate Your Workflow. Get a real-time feed of all EDX Medical Group Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EDX Medical Group Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EDX Medical Group Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
